Research into Myositis‐specific autoantibodies

Myositis‐specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies

Wong VTL, So H, Lam TTO, et al
Acta Neurologica Scandinavica|August 11, 2020

This multi‐centered studywas done on adult Chinese patients with idiopathic inflammatory myopathies (IIMs) in regional hospitals in Hong Kong from July 2016 to January 2018. 

Aim: to discover the prevalence of Myositis‐specific autoantibodies (MSAs) and their associated complications in a cohort of patients with idiopathic inflammatory myopathies (IIMs).

Findings: different antibodies were detected. 

Conclusions: MSA testing means patients with IIMs can be divided into subgroups and easier prediction of potentially life‐threatening complications.

Read the full article at Acta Neurologica Scandinavica.

Myositis is an autoimmune disease where the body attacks healthy muscle fibers causing muscle inflammation, and eventually, loss of strength, functionality and mobility. It can be life-threatening when it affects the lungs and heart, but fortunately, there are medications and therapies to effectively treat the condition. ~ Hospital for Special Surgery